By Caroll Neubauer
Leaders of the medical device industry expressed confidence last week that the votes are there in the U.S. Senate for a full repeal of the medical device tax, slated to go into effect in January 2013.
"At the moment, I’m still betting that the tax will be repealed," B.Braun Medical CEO Caroll Neubauer told audience members at the AdvaMed 2012 conference in Boston. "We have a bill in the U.S. Senate, which if it gets to the floor would pass. It would get 53 or 54 votes from outspoken senators, including Democrats, who are going to vote for it.
Globus Medical filed for an initial public offering yesterday, saying it’s planning a reverse split of its existing stock just before the IPO launches.
The Audubon, Pa.-based orthopedic device maker, which ran afoul of the FDA last month, said it hopes to trade under the "GMED" ticker on the New York Stock Exchange.
NxStage Medical (NSDQ:NXTM) extended a supply agreement with B. Braun Medical to supply the Bethlehem, Pa.-based company with its Streamline blood tubing sets, Medisystems MasterGuard and Buttonhole needles.
The contract was originally signed by the 2 companies in October 2004 and calls for NxStage to supply tubing sets B. Braun Medical’s Dialog and Dialog+ hemodialysis systems.
Hospital group purchasing organizations Novation and Premier signed seven new contracts this week for everything from surgical safety technology to central venous access catheters.
Novation awarded a three-year contract to Teleflex Inc. (NYSE:TFX) for its respiratory, anesthesia airway, central venous access, endotracheal tubes and chest drainage products.
If you don’t think the impending medical device tax is a big deal, just ask Caroll Neubauer’s cardiologist.
The chairman & CEO of B.Braun’s North American business admits that just talking about the tax, slated to go into effect in 2013, gets his blood pressure up immediately.
Veteran surgical devices maker and B. Braun Medical Inc. subsidiary Aesculap Inc. snapped up Aragon Surgical Inc. and its radiofrequency electrosurgical instruments for tissue fusion and cutting.
Aragon’s Caiman instruments are the only radiofrequency devices on the market with an articulating end to allow surgeons more maneuverability with tissue fusion and cutting during surgery.
Medtronic Inc.’s (NYSE:MDT) got the go-ahead to pursue trials of its Symplicity catheter system for treating hypertension via renal denervation.
The system includes a catheter inserted into the renal artery near each kidney via the femoral artery in the upper thigh. A generator on the tip of the catheter delivers lower-power radio-frequency energy to "deactivate" the sympathetic nerves, lowering blood pressure.
Ben Franklin Technology Partners of Northeastern Pennsylvania invested $60,000 in two Lehigh Valley, Pa.-based medical companies.
The Bethlehem, Pa.-based, state-funded organization invested $50,000 in HealthOneMed Inc. and $10,000 in B. Braun Medical Inc.
Allentown, Pa.-based HealthOneMed plans to employ the funding to complete a marketing plan for its first product, Dispense-A-Pill, a patented device that dispenses pharmaceutical tablets on a pre-programmed schedule.